logo
Select company
Select metric
$ -25.39MNet Cash Flow - Issuance (Repayment) of Debt Securities
VS
Market
78
Sector
89
Industry
96
History
95
$ 11.01Close
$ 4.26 - $ 15.16 52-Week Range
Ticker Information

Ticker

ENTA

Company Name

ENANTA PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ENANTA PHARMACEUTICALS INC - Net Cash Flow - Issuance (Repayment) of Debt Securities Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ENTA - CF - Debt Historical data
DateNet Cash Flow - Issuance (Repayment) of Debt Securities
6/30/2025$ -25.39M
3/31/2025$ -25.64M
12/31/2024$ -25.25M
9/30/2024$ -27.48M
6/30/2024$ -20.21M
3/31/2024$ 186.13M
12/31/2023$ 192.51M
9/30/2023$ 199.68M
6/30/2023$ 199.68M
3/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ENANTA PHARMACEUTICALS INC's latest trailing twelve months (TTM) CF - Debt stands at $ 0.
  • Over the past 5 years, ENANTA PHARMACEUTICALS INC's average CF - Debt has been $ 32.7M.
  • The median CF - Debt for ENANTA PHARMACEUTICALS INC during this period was $ 0
  • ENANTA PHARMACEUTICALS INC reached its highest CF - Debt over the past 5 years at $ 199.68M.
  • The lowest CF - Debt recorded by ENANTA PHARMACEUTICALS INC in the same timeframe $ -27.48M

ENANTA PHARMACEUTICALS INC's CF - Debt vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Debt Benchmarks
CompanyCF - Debt
THTX : THERATECHNOLOGIES INC $ -16.64MBDTX : BLACK DIAMOND THERAPEUTICS INC $ 0PLX : PROTALIX BIOTHERAPEUTICS INC $ -20.42MALEC : ALECTOR INC $ 9.39MSGMO : SANGAMO THERAPEUTICS INC $ 0CSBR : CHAMPIONS ONCOLOGY INC $ -151KSPRO : SPERO THERAPEUTICS INC $ 0CCCC : C4 THERAPEUTICS INC $ 0TRDA : ENTRADA THERAPEUTICS INC $ 0CELU : CELULARITY INC $ 285K

Similar metrics to CF - Debt:

Definition of Net Cash Flow - Issuance (Repayment) of Debt Securities

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from issuance (repayment) of debt.

ENTA - Net Cash Flow - Issuance (Repayment) of Debt Securities, Last 5 years

$ -27.48M

Minimum

Sep 30, 2024

$ 199.68M

Maximum

Jun 30, 2023

$ 32.7M

Average

$ 0

Median

CF - Debt Benchmark Analysis

 The chart above depicts the distribution of CF - Debt for companies in the Total Stock Market. The average CF - Debt of the companies is $ -1.66M with a standard deviation of $ 24.14M.
The following table provides additional summary stats:
CF - Debt in the Market:
filtered constituents2.85K
min$ -84.35M
max$ 83.81M
average$ -1.66M
median$ 0
std$ 24.14M